BTB 09702
Latest Information Update: 06 Oct 2006
At a glance
- Originator Otsuka Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Kidney disorders
Most Recent Events
- 06 Oct 2006 Discontinued - Preclinical for Kidney disorders in Japan (unspecified route)
- 07 Jan 2002 New profile
- 07 Jan 2002 Preclinical development for Kidney disorders in Japan (Unknown route)